stockportfolio.pro
Stocks / CON vs OGN
CON vs OGN
Concentra Group Holdings Parent, Inc. and Organon & Co. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Concentra Group Holdings Parent, Inc. (CON) | Organon & Co. (OGN) | |
|---|---|---|
| Market cap | $3.4B | $3.5B |
| Revenue (latest FY) | $2.16B | $6.22B |
| Net income (latest FY) | $166.41M | $187.00M |
| Revenue growth (5y CAGR) | 7.9% | -1.0% |
| Net margin | 7.7% | 3.0% |
| Return on equity | 42.3% | 24.9% |
| P/E ratio | 19.0 | 14.4 |
| Dividend yield | 1.0% | 0.6% |
| Profitable years (of last 10) | 4 | 7 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CON — free Open OGN — freeFrequently asked questions
Which is bigger, CON or OGN?
Organon & Co. is larger by market capitalization — $3.5B versus $3.4B.
Which grows faster, CON or OGN?
Over the last five fiscal years, Concentra Group Holdings Parent, Inc. grew revenue faster — 7.9%/yr versus -1.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.